Summit Therapeutics SMMT Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's shares (basic)?
- Summit Therapeutics (SMMT) reported shares (basic) of 775.5M in Q1 2026.
- How has Summit Therapeutics's shares (basic) changed year-over-year?
- Summit Therapeutics's shares (basic) increased by 5.1% year-over-year, from 738.1M to 775.5M.
- What is the long-term trend for Summit Therapeutics's shares (basic)?
- Over 4 years (2021 to 2025), Summit Therapeutics's shares (basic) has grown at a 64.5% compound annual growth rate (CAGR), from 405.6M to 3B.
- What does shares (basic) mean?
- The average number of shares held by investors during the period.
- How do you interpret shares (basic)?
- An increase suggests share issuance, which can dilute existing shareholders, while a decrease suggests share buybacks.
- How does shares (basic) compare across companies?
- Used to normalize earnings metrics across different companies regardless of their total share count.